Oura Secures $200 Million in Series D Funding, Eyes Expansion and Innovation
In an exciting development for wearable tech enthusiasts, Oura, the innovative smart ring company, has successfully closed a $200 million Series D funding round. This impressive financial boost elevates the company’s valuation to a remarkable $5.2 billion.
Key Investors and Strategic Partnerships
The funding round saw significant contributions from Fidelity Management and glucose device maker Dexcom. This influx of capital is set to propel Oura’s ambitions to broaden its product range and deepen its investment in areas such as product development, science, and AI.
“As we continue to drive momentum and growth, we are bolstered by the additional support of these investors,” said Oura CEO Tom Hale in a press release.
— Tom Hale, CEO of Oura
Innovative Collaborations on the Horizon
This funding news follows Oura’s recent announcement of a strategic partnership with Dexcom. Together, they aim to integrate their devices and apps, opening new doors for users to monitor their blood sugar levels seamlessly. The collaboration promises co-marketing efforts and cross-selling opportunities between the two companies.
Driving Market Innovation and Growth
Oura’s journey is indeed a tale of remarkable growth. The company boasts sales of over 2.5 million rings, with its member base and revenue doubling in the past year alone. Their retail footprint has expanded into giants like Amazon and Target. Moreover, collaborations with organizations such as the Naval Health Research Center and the Air Force are putting smart rings on service members’ fingers.
Strategic Acquisitions Fuel Future Prospects
- In October, Oura acquired Sparta Science, a health tracking startup based in the Bay Area.
- The previous month saw them acquiring Veri, a Helsinki-based startup known for its metabolic health products.
Oura’s forward-thinking approach is setting the stage for transformative health tech solutions. As CEO Tom Hale emphasizes, “We’ve made significant progress in advancing our mission to make health a daily practice and will use this funding to unlock new opportunities, with AI development at the center of our strategy.”
As Oura continues on this promising trajectory, it reaffirms its potential to change lives at scale while leading the market through cutting-edge innovation and strategic growth opportunities that extend beyond the ring.